Raw data 16–20. by Fateme Khorramroo (18086501)

“…Transverse ankle-hip coordination showed an in-phase pattern in wide conditions during push-off (p=0.044), during LR (p=0.022). Wide walking, significantly increased coordination variability of the sagittal ankle-knee during LR and decreased transverse ankle-hip during push-off. …”

Demographics, SD= Standard Deviation. by Fateme Khorramroo (18086501)

“…Transverse ankle-hip coordination showed an in-phase pattern in wide conditions during push-off (p=0.044), during LR (p=0.022). Wide walking, significantly increased coordination variability of the sagittal ankle-knee during LR and decreased transverse ankle-hip during push-off. …”

Raw data 6–9 and 15. by Fateme Khorramroo (18086501)

“…Transverse ankle-hip coordination showed an in-phase pattern in wide conditions during push-off (p=0.044), during LR (p=0.022). Wide walking, significantly increased coordination variability of the sagittal ankle-knee during LR and decreased transverse ankle-hip during push-off. …”

Raw data 1–5. by Fateme Khorramroo (18086501)

“…Transverse ankle-hip coordination showed an in-phase pattern in wide conditions during push-off (p=0.044), during LR (p=0.022). Wide walking, significantly increased coordination variability of the sagittal ankle-knee during LR and decreased transverse ankle-hip during push-off. …”

Raw data 10–14. by Fateme Khorramroo (18086501)

“…Transverse ankle-hip coordination showed an in-phase pattern in wide conditions during push-off (p=0.044), during LR (p=0.022). Wide walking, significantly increased coordination variability of the sagittal ankle-knee during LR and decreased transverse ankle-hip during push-off. …”

Coordination angle during running. by Fateme Khorramroo (18086501)

“…Transverse ankle-hip coordination showed an in-phase pattern in wide conditions during push-off (p=0.044), during LR (p=0.022). Wide walking, significantly increased coordination variability of the sagittal ankle-knee during LR and decreased transverse ankle-hip during push-off. …”

Gait retraining with biofeedback. by Fateme Khorramroo (18086501)

“…Transverse ankle-hip coordination showed an in-phase pattern in wide conditions during push-off (p=0.044), during LR (p=0.022). Wide walking, significantly increased coordination variability of the sagittal ankle-knee during LR and decreased transverse ankle-hip during push-off. …”

Coordination angle during walking. by Fateme Khorramroo (18086501)

“…Transverse ankle-hip coordination showed an in-phase pattern in wide conditions during push-off (p=0.044), during LR (p=0.022). Wide walking, significantly increased coordination variability of the sagittal ankle-knee during LR and decreased transverse ankle-hip during push-off. …”

Cinnamaldehyde is a specific ligand for HL-IR. by Ceyan Kuang (8554557)

Flowchart of study population. by Yan Zeng (120271)

“…</p><p>Conclusions</p><p>In MM patients in ICU, both minimum and maximum PLT were significantly associated with an increased risk of in-hospital mortality in critical ill patients with MM. …”

Stata file for the experimental hut data. by Jackline L. Martin (12265386)

“…Overall, Interceptor G2 LLINs induced higher 72-hour mortality compared to standard LLINs of the same age up to12 months (44% vs 21%, OR: 3.5, 95% CI: 1.9–6.6, p-value < 0.001), and 24-hour mortality was only significantly higher in Olyset Plus when new (OR: 13.6, 95%CI: 4.4–41.3, p-value < 0.001) compared to standard LLINs but not at 12 months (17% vs 13%; OR: 2.1, 95% CI: 1.0–4.3; p-value = 0.112). …”

EHT treatments evaluated. by Jackline L. Martin (12265386)

“…Overall, Interceptor G2 LLINs induced higher 72-hour mortality compared to standard LLINs of the same age up to12 months (44% vs 21%, OR: 3.5, 95% CI: 1.9–6.6, p-value < 0.001), and 24-hour mortality was only significantly higher in Olyset Plus when new (OR: 13.6, 95%CI: 4.4–41.3, p-value < 0.001) compared to standard LLINs but not at 12 months (17% vs 13%; OR: 2.1, 95% CI: 1.0–4.3; p-value = 0.112). …”

Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography by Mengjing Ji (17741338)

“…PET/CT imaging showed significantly higher uptake of [⁶⁸Ga]Ga-DOTA-Bua-CDKi (8.40 ± 0.85%ID/g) in MCF-7 tumors 60 min after tracer injection, with significant differences in tumor uptake among the three models (<i>P</i> < 0.05). …”

Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography by Mengjing Ji (17741338)

“…PET/CT imaging showed significantly higher uptake of [⁶⁸Ga]Ga-DOTA-Bua-CDKi (8.40 ± 0.85%ID/g) in MCF-7 tumors 60 min after tracer injection, with significant differences in tumor uptake among the three models (<i>P</i> < 0.05). …”

Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography by Mengjing Ji (17741338)

“…PET/CT imaging showed significantly higher uptake of [⁶⁸Ga]Ga-DOTA-Bua-CDKi (8.40 ± 0.85%ID/g) in MCF-7 tumors 60 min after tracer injection, with significant differences in tumor uptake among the three models (<i>P</i> < 0.05). …”

Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography by Mengjing Ji (17741338)

“…PET/CT imaging showed significantly higher uptake of [⁶⁸Ga]Ga-DOTA-Bua-CDKi (8.40 ± 0.85%ID/g) in MCF-7 tumors 60 min after tracer injection, with significant differences in tumor uptake among the three models (<i>P</i> < 0.05). …”

Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography by Mengjing Ji (17741338)

“…PET/CT imaging showed significantly higher uptake of [⁶⁸Ga]Ga-DOTA-Bua-CDKi (8.40 ± 0.85%ID/g) in MCF-7 tumors 60 min after tracer injection, with significant differences in tumor uptake among the three models (<i>P</i> < 0.05). …”

Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography by Mengjing Ji (17741338)

“…PET/CT imaging showed significantly higher uptake of [⁶⁸Ga]Ga-DOTA-Bua-CDKi (8.40 ± 0.85%ID/g) in MCF-7 tumors 60 min after tracer injection, with significant differences in tumor uptake among the three models (<i>P</i> < 0.05). …”

Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography by Mengjing Ji (17741338)

“…PET/CT imaging showed significantly higher uptake of [⁶⁸Ga]Ga-DOTA-Bua-CDKi (8.40 ± 0.85%ID/g) in MCF-7 tumors 60 min after tracer injection, with significant differences in tumor uptake among the three models (<i>P</i> < 0.05). …”

Current vaccine delivery model. by Pamela Bakkabulindi (12914980)

“…Monthly distribution costs decreased from $494.8 ($0.07 per child) to $445.9 ($0.06 per child). …”